- Home
- GOF
as of 03-11-2026 3:59pm EST
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.4B | IPO Year: | 2006 |
| Target Price: | N/A | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $11.08 - $15.93 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Guggenheim Strategic Opportunities Fund of Beneficial Interest (GOF)
Director, Other
Avg Cost/Share
$11.59
Shares
4,180
Total Value
$48,446.20
Owned After
6,231
SEC Form 4
Director, Other
Avg Cost/Share
$12.13
Shares
412
Total Value
$4,997.56
Owned After
5,010
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Barnes Randall C | GOF | Director, Other | Mar 6, 2026 | Buy | $11.59 | 4,180 | $48,446.20 | 6,231 | |
| NYBERG RONALD | GOF | Director, Other | Dec 18, 2025 | Buy | $12.13 | 412 | $4,997.56 | 5,010 |
Compare GOF vs Leading Stocks
See how GOF stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.